Necrotizing Fasciitis: Why Can Early Surgery Save Lives?
Quick Facts
What warning signs suggest a dangerous deep skin infection?
The new BMJ clinical review examines diagnosis and management across skin and soft tissue infections, focusing on cellulitis and abscesses. A related concern is recognizing when infection involves deeper tissues and requires emergency surgical care. Necrotizing fasciitis is an uncommon but potentially fatal example. The BMJ publication reviews existing evidence; it is not a new treatment trial. [BMJ review](https://pubmed.ncbi.nlm.nih.gov/42727947/)
According to the CDC, early symptoms can include rapidly spreading warmth or swelling, fever, and severe pain extending beyond the visibly affected area. Blisters, dark discoloration and dizziness can develop later. Seek emergency care for severe pain with rapidly worsening skin changes, especially after an injury or operation; do not wait for blackened skin. [CDC symptoms and emergency advice](https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html)
Why can necrotizing fasciitis be difficult to diagnose?
The visible skin changes may initially underestimate the infection underneath. CDC guidance highlights pain that is much greater than the local skin findings would suggest, along with severe illness out of proportion to those findings. These clues require clinical judgment because early symptoms overlap with other infections. [CDC diagnostic guidance](https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/necrotizing-fasciitis.html)
CT or MRI can help identify swelling in deep tissues or gas, but imaging is not definitive. Gas is often absent in streptococcal necrotizing fasciitis. When suspicion is high, surgical exploration should proceed promptly, with tissue testing to help identify the bacteria. Imaging should never delay that assessment. [CDC testing recommendations](https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/necrotizing-fasciitis.html)
What does research show about how quickly surgery is needed?
A 2020 systematic review by Nawijn and colleagues examined surgical timing in necrotizing soft tissue infections. Across 10 studies comparing surgery within six hours of hospital presentation with later surgery, reported mortality was 19% versus 32%. These are the figures summarized above; the clock started at hospital presentation, not when symptoms began. [Systematic review and meta-analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC6950871/)
The underlying evidence was largely observational, so differences in patients and care may influence the comparison. The findings do not establish a safe six-hour waiting period or predict an individual's outcome. They support treating suspected necrotizing infection urgently. [Study findings and limitations](https://pmc.ncbi.nlm.nih.gov/articles/PMC6950871/)
Treatment combines intravenous antibiotics with surgery to remove dead tissue. Damaged blood supply can prevent antibiotics from reaching every infected area, explaining why medication alone may be insufficient. Some patients need repeated operations as clinicians reassess the tissue. [CDC treatment overview](https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html)
Frequently Asked Questions
Yes. Although conditions such as diabetes and cancer increase risk, healthy people can also develop it. Severe symptoms require urgent assessment regardless of medical history. [CDC risk factors](https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/necrotizing-fasciitis.html)
No. Bacteria often enter through broken skin, but infection can also follow an injury that does not visibly break the skin. [CDC causes and risk factors](https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html)
Rapidly spreading swelling or severe, worsening pain requires immediate reassessment. Suspected necrotizing fasciitis needs emergency hospital treatment, which generally includes surgery and intravenous antibiotics. [CDC emergency advice](https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html)
References
- Long B, Yadav K, Rech MA, Gottlieb M. Advances in the diagnosis and management of skin and soft tissue infections. BMJ. 2026;394:e100580. Published September 10, 2026. [Publication record](https://pubmed.ncbi.nlm.nih.gov/42727947/)
- Centers for Disease Control and Prevention. Clinical Guidance for Type II Necrotizing Fasciitis. August 5, 2025. [Clinical guidance](https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/necrotizing-fasciitis.html)
- Centers for Disease Control and Prevention. About Necrotizing Fasciitis. August 7, 2025. [Patient information](https://www.cdc.gov/group-a-strep/about/necrotizing-fasciitis.html)
- Nawijn F, et al. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World Journal of Emergency Surgery. 2020;15:4. [Full article](https://pmc.ncbi.nlm.nih.gov/articles/PMC6950871/)